@article{f721c01e37854fbba69e4e6b0738bbdd,
title = "Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes",
author = "Swords, {R. T.} and J. Watts and Erba, {H. P.} and Altman, {J. K.} and M. Maris and F. Anwer and Z. Hua and H. Stein and H. Faessel and F. Sedarati and Dezube, {B. J.} and Giles, {F. J.} and Medeiros, {B. C.} and DeAngelo, {D. J.}",
note = "Funding Information: This research was supported by Takeda Pharmaceuticals, Inc. This study is registered with ClinicalTrials.gov, number NCT00677170. RTS received support from grant NIH 1KL2TR000461.",
year = "2017",
month = feb,
day = "3",
doi = "10.1038/bcj.2017.1",
language = "English (US)",
volume = "7",
journal = "Blood cancer journal",
issn = "2044-5385",
publisher = "Springer Nature",
number = "2",
}
